# Risk, Rigor, and Reality: Suan Tuang on Investing Across Private and Public Biotech

Page: https://stenobird.com/podcast/the-nextgen-vc-podcast-6617779/risk-rigor-and-reality-suan-tuang-on-investing-across-private-and-public-biotech
Text version: https://stenobird.com/podcast/the-nextgen-vc-podcast-6617779/risk-rigor-and-reality-suan-tuang-on-investing-across-private-and-public-biotech.md
Podcast: [The NextGen VC Podcast](https://stenobird.com/podcast/the-nextgen-vc-podcast-6617779)
Published: 2026-02-04T17:56:49+00:00
Episode link: https://podcasters.spotify.com/pod/show/nextgenvcpodcast/episodes/Risk--Rigor--and-Reality-Suan-Tuang-on-Investing-Across-Private-and-Public-Biotech-e3ekvb1
Audio file: https://anchor.fm/s/e77f3ea0/podcast/play/115030817/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-4%2F417469301-44100-2-75a57a0fd5a5.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-nextgen-vc-podcast-6617779/episodes/risk-rigor-and-reality-suan-tuang-on-investing-across-private-and-public-biotech
Duration seconds: 2810

## Resource

Suan Tuang didn’t take a traditional path into biotech investing, and this journey shapes how he evaluates risk today. Now at TCG Crossover, and with prior experience at Foresite and Eventide, Suan brings a clinician-scientist lens to investing across private and public markets. In this episode, Suan shares how his immigrant journey and academic challenges at MIT and Harvard have shaped his unique approach to risk and resilience. Learn how he leverages clinical data over hype, balances scientific rigor with market realities, and more. Suan also offers practical advice for aspiring investors and entrepreneurs. Tune in for actionable insights and inspiration. This episode may feature current or former clients of Wilson Sonsini. This podcast is for general informational purposes and is not intended to provide and should not be relied on as legal advice. The information in this podcast is not tailored to a particularized situation or jurisdiction, may not reflect the current state of the law, and should not be considered a substitute for the advice of your own legal counsel. You should not consider this podcast an invitation to form an attorney-client relationship, and no attorney-client relationship is created by your use of this podcast. Wilson Sonsini disclaims all liability in respect to any actions taken or not taken based on the content of this podcast and notes that prior results do not guarantee a similar outcome. This podcast may be considered attorney advertising in certain jurisdictions.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-nextgen-vc-podcast-6617779/episodes/risk-rigor-and-reality-suan-tuang-on-investing-across-private-and-public-biotech/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-nextgen-vc-podcast-6617779/risk-rigor-and-reality-suan-tuang-on-investing-across-private-and-public-biotech.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.